îāļāđāļāļŦāļē
îž
î
āļĨāđāļāļāļāļīāļ
îāļāđāļāļŦāļē
î
Exicure Inc
XCURîāđāļāļīāđāļĄāļĨāļāđāļāļĢāļēāļĒāļāļēāļĢāļāļīāļāļāļēāļĄ
1.290USD
0.0000.00%
āđāļ§āļĨāļēāļāļģāļāļēāļĢāļāļĨāļēāļÂ 09/22, 14:32ïžETïž
8.22MāļĄāļđāļĨāļāđāļēāļāļĨāļēāļ
āļāļēāļāļāļļāļP/E TTM
āđāļāļĩāđāļĒāļ§āļāļąāļ Exicure Inc āļāļĢāļīāļĐāļąāļ
Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The Company is also exploring strategic alternatives to maximize stockholder value.
Exicure Inc āđāļāļĢāđāļāļĨāđ
îāļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļXCUR
āļāļ·āđāļāļāļĢāļīāļĐāļąāļExicure Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 09, 2018
āļāļĩāļāļĩāđāļYoo (Andy)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ7
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļMay 09
āļāļĩāđāļāļĒāļđāđ2430 N. Halsted St.
āđāļĄāļ·āļāļCHICAGO
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ60614
āđāļāļĢāļĻāļąāļāļāđ18476731707
āđāļ§āđāļāđāļāļāđhttps://www.exicuretx.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļXCUR
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 09, 2018
āļāļĩāļāļĩāđāļYoo (Andy)
āļāļđāđāļāļĢāļīāļŦāļēāļĢāļāļĢāļīāļĐāļąāļāļāļāļ Exicure Inc
îāļāļ·āđāļ
āļāļ·āđāļ/āļāļģāđāļŦāļāđāļ
āļāļģāđāļŦāļāđāļ
āļāļēāļĢāļāļ·āļāļŦāļļāđāļ
āđāļāļĨāļĩāđāļĒāļ
Mr. Dongho Lee
Mr. Dongho Lee
Independent Director
Independent Director
--
--
Mr. Andy Yoo
Mr. Andy Yoo
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Seung Ik Baik
Mr. Seung Ik Baik
Chief Financial Officer, Secretary, Director
Chief Financial Officer, Secretary, Director
--
--
Mr. Sangjn Yeo
Mr. Sangjn Yeo
Independent Director
Independent Director
--
--
Ms. Aejin Hwang
Ms. Aejin Hwang
Independent Director
Independent Director
--
--
Dr. Josephine (Pina) Cardarelli, Ph.D.
Dr. Josephine (Pina) Cardarelli, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Jung Soo Kim
Mr. Jung Soo Kim
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Gyeung Seog Cheon
Mr. Gyeung Seog Cheon
Director
Director
--
--
Mr. Gyuyeob (Dario) Lee
Mr. Gyuyeob (Dario) Lee
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. Yoontae Han
Mr. Yoontae Han
Director
Director
--
--
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
āļāļ·āđāļ
āļāļ·āđāļ/āļāļģāđāļŦāļāđāļ
āļāļģāđāļŦāļāđāļ
āļāļēāļĢāļāļ·āļāļŦāļļāđāļ
āđāļāļĨāļĩāđāļĒāļ
Mr. Dongho Lee
Mr. Dongho Lee
Independent Director
Independent Director
--
--
Mr. Andy Yoo
Mr. Andy Yoo
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Seung Ik Baik
Mr. Seung Ik Baik
Chief Financial Officer, Secretary, Director
Chief Financial Officer, Secretary, Director
--
--
Mr. Sangjn Yeo
Mr. Sangjn Yeo
Independent Director
Independent Director
--
--
Ms. Aejin Hwang
Ms. Aejin Hwang
Independent Director
Independent Director
--
--
Dr. Josephine (Pina) Cardarelli, Ph.D.
Dr. Josephine (Pina) Cardarelli, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
āļāļģāļāļēāļĄāļāļĩāđāļāļāļāđāļāļĒ
āđāļāļĢāļāļ·āļāļāļđāđāļāļ·āļāļŦāļļāđāļāļŦāđāļēāļāļąāļāļāļąāļāđāļĢāļāļāļāļ Exicure Inc?
îāļāļđāđāļāļ·āļāļŦāļļāđāļāļŦāđāļēāļāļąāļāļāļąāļāđāļĢāļāļāļāļ Exicure Inc āđāļāđāđāļāđ: Mr. Dongho Lee